News
11h
ScienceAlert on MSNUp to 13% of Dementia Cases May Actually Be a Misdiagnosed Treatable ConditionAs the global population ages, more of us face frightening cognitive decline, personally or in our loved ones.
Background and Aim: Development of overt hepatic encephalopathy (HE) is associated with poor prognosis in patients with cirrhosis. Lactulose is used for the treatment of HE. There is no study on ...
He added: 'Undiagnosed cirrhosis and potential hepatic encephalopathy can be a treatable cause of or contributor towards cognitive impairment in patients diagnosed with dementia.' Liver cirrhosis ...
Hosted on MSN3mon
Study shows 13% of patients with dementia may instead have cognitive decline from cirrhosisIt can be difficult for physicians to differentiate dementia from hepatic encephalopathy, which is the cognitive decline caused by cirrhosis. If it is undetected, patients may not receive ...
China: A recent retrospective cohort study has highlighted the significant role of pulmonary infections in influencing ...
In the phase 1 trial, up to twenty patients with ACLF and hepatic encephalopathy and ineligible for transplant will be ...
In addition to lowering serum cholesterol, statins have pleiotropic effects via their anti-inflammatory properties, which ...
CAMBRIDGE, Mass. & OXFORD, England, April 15, 2025--eGenesis and OrganOx Announce U.S. FDA Clearance of IND Application for ...
Patients with cirrhosis and minimal hepatic encephalopathy often experience sleep difficulties, but treatment with benzodiazepines is frequently ineffective and can have serious side effects.
The FDA has cleared the first clinical trial to test genetically engineered pig livers in patients who have acute-on-chronic liver failure. The trial will evaluate the use of a Egenesis porcine liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results